Morrison Jodie Pope

CEO, DirectorQ32 Bio Inc. (QTTB) · full profile →Form 4 · filed Feb 26, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
9
1 non-derivative · 8 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2025Grant(A)132K$0132K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Feb 24, 2025Grant(A)394K$0394K
Feb 24, 2025Grant(A)17K$017K
Feb 24, 2025Disposed to issuer(D)17K$00
Feb 24, 2025Grant(A)153K$0153K
Feb 24, 2025Disposed to issuer(D)153K$00
Feb 24, 2025Grant(A)153K$0153K
Feb 24, 2025Disposed to issuer(D)153K$00
Feb 24, 2025Disposed to issuer(D)394K$00

Transaction Codes

A
Grant / award
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000950170-25-028261) within minutes of acceptance. Every field above traces to the original document. Verify it directly: